Health-related quality of life (HRQOL) of systemic lupus erythematosus (SLE) patients with hip arthroplasty after medium to long-term follow-up has not been reported. We conducted a retrospective study for SLE patients with osteonecrosis of the femoral head (ONF). Forty-seven consecutive arthroplasties were performed in 36 patients. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Medical Outcome Survey Short Form 36 (SF-36) and Harris hip score were evaluated. Two patients died before the four-year follow-up and two patients were lost to follow-up. The remaining 43 hips in 32 patients with an average age at surgery of 35 years and an average follow-up of 12.0 years (range 4.0—25.0) were assessed. Bipolar hemiarthroplasty was performed for 18 hips in 12 patients, and total hip arthroplasty (THA) was performed for 25 hips in 20 patients. The mean WOMAC scores for pain and function at the recent followup were 90.8 ± 8.5points and 79.0 ± 18.3 points. Patients with THA had significantly high scores in SF-36 physical functioning (P < 0.05) and bodily pain (P < 0.03) compared to those with bipolar hemiarthroplasty. Although improvement could not reach the level of general population, the hip arthroplasty contributed to support HRQOL of SLE patients. Lupus (2007) 16, 1—6.
Dubois EL, Cozen L.Avascular (aseptic) bone necrosis associated with-systemic lupus erythematosus . JAMA1960; 174: 966—984.
2.
Weiner ES, Abeles M.Aseptic necrosis and glucocorticosteroids in systemiclupus erythematosus: a reevaluation. J Rheumatol1989; 16: 604—608.
3.
Zizic TM, Marcoux C., Hungerford DS, Dansereau J-A., Stevens MBCorticosteroid therapy associated with ischemic necrosis of bone in systemiclupus erythematosus. Am J Med1985; 79: 596—604.
4.
Mont MA, Glueck CJ, Pacheco IH, Wang P., Hungerford DS, Petri M.Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol1997; 24: 654—662.
5.
Mok MY, Farewell VT, Isenberg DARisk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?Ann Rheum Dis2000; 59: 462—467.
6.
Nagasawa K., Tada Y., Koarada S., Horiuchi T., Tsukamoto H., Murai K., Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus2005; 14: 385—390.
7.
Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V., Hallet DC, Cook RJPredictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol2001; 28: 761—765.
8.
Sarmiento A. , Ebramzadeh E., Gogan WJ, McKellop HATotal hip arthroplasty with cement: a long-term radiographic analysis in patients who are older than fifty and younger than fifty years. J Bone Joint Surg Am1990; 72: 1470—1476.
9.
Stulberg BN, Singer R., Goldner J., Stulberg J.Uncemented total hip arthroplasty in osteonecrosis: a 2- to 10-year evaluation . Clin Orthop1997; 334: 116—123.
10.
Callahan CM , Drake BG, Heck DA, Dittus RSPatient outcomes followingtricompartmental total knee replacement: a meta-analysis. JAMA1994; 271: 1349—1357
11.
Baron JA, Barrett J., Katz JN, Liang MHTotal hip arthroplasty: use and select complications in the US Medicare population . Am J Publ Health1996; 86: 70—72.
12.
Coyte P., Wang PP, Hawker G., Wright JGThe relationship between variationsin knee replacements utilization rates and reported prevalence of arthritis Ontario, Canada. J Rheumatol1997; 24: 2403—2412
13.
Bayley KB, London MR, Grunkemeier GL, Lansky DJMeasuring the success of treatment in patient terms. Med Care1995; 33(Suppl): AS226—235.
14.
Rissanen P., Aro S., Sintonen H., Slattis P.Paavolainen P.Quality of life and functional ability in hip and knee replacement: a prospective study. Qual Life Res1996; 5: 56—64.
15.
Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor MEHealth related quality of life outcomes after total hip and knee arthroplasties in a community based population. J Rheumatol2000; 27: 1745—1752.
16.
Thumboo J., Fong KY, Chan SP et al. A prospective study of factorsaffecting quality of life in systemic lupus erythematosus. J Rheumatol2000; 27: 1414—1420.
17.
Dobkin PL, da Costa D., Dritsa M. et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res1999; 12: 401—410.
18.
Rinaldi S., Ghisi M., Iaccarino L. et al. Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus. Arthritis Rheum2006; 55: 427—433.
19.
Prupas HM, Patzakis M., Quismorio FP Jr.Total hip arthroplasty foravascular necrosis of the femur in systemic lupus erythematosus. Clin Orthop Relat Res1981; 161: 186—190.
20.
Kunec JRTotal hip replacement in patients under thirty-five years of age. Orthopaedics1983; 6: 1432—1434.
21.
Chen PG, Lin CCTotal hip arthroplasty in patients with systemic lupus erythematosus. Taiwan Yi Xue Hui Za Zhi1987; 86: 299—306.
22.
Hanssen AD, Cabanela ME, Michet CJ Jr.Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Joint Surg Am1987; 69: 807—814.
23.
Huo MH, Salvati EA, Browne MG, Pellicci PM, Sculco TP, Johanson NAPrimary total hip arthroplasty in systemic lupus erythematosus. J Arthroplasty1992; 7: 51—56
24.
Zangger P., Gladman DD, Urowitz MB, Bogoch EROutcome of total hip replacement for avascular necrosis in systemic lupus erythematosus. J Rheumatol2000; 27: 919—923.
25.
Ware JE Jr, Sherbourne CDThe MOS 36-item short-form health survey(SF-36). I: conceptual framework and item selection. Med Care1992; 30: 473—483.
26.
Bellamy N., Buchanan WW, Goldsmith CH, Campbell J., Stitt LWValidation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes following total hip and knee arthroplasty in osteoarthritis. J OrthopRheumatol1988 ; 1: 95—108.
27.
Bellamy N., Buchanan WW, Goldsmith CH, Campbell J., Stitt LWValidation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol1988; 15:1833—1840.
28.
Fukuhara S. , Bito S., Green J., Hsiao A., Kurokawa K.Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol1998; 51: 1037—1044.
29.
Fukuhara S. , Ware JE, Kosinski M., Wada S., Gandek B.Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol1998; 51: 1045—1053.
30.
Harris WHTraumatic arthritis of the hip after dislocation and acetabularfracture: Treatment by mold arthroplasty. J Bone Joint Surg Am1969; 51: 737—755.
31.
Harris WH, Schiller AL, Scholler J-M., Freiberg RA, Scott R.Extensive localized bone resorption in the femur following total hip replacement . J Bone Joint Surg Am1976; 58: 612—618.
32.
Callaghan JJ , Dysart SH, Savory CGThe uncemented porouscoatedanatomic total hip prosthesis: Two-year results of a prospective consecutive series. J Bone Joint Surg Am1988; 70: 337—346
Toloza SM, Uribe AG, McGwin G. Jr et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictorsof vascular events. Arthritis Rheum2004; 50: 3947—3957.
35.
Ito H., Matsuno T., Kaneda K.Bipolar hemiarthroplasty for osteonecrosis of the femoral head: a 7- to 18-year followup. Clin Orthop Relat Res2000; 374: 201—211.
36.
Lieberman JR , Berry DJ, Montv MA et al. Osteonecrosis of the hip: management in the twenty-first century. J Bone Joint Surg Am2002; 84: 834—853.
37.
Lee SB, Sugano N., Nakata K., Matsui M., Ohzono K.Comparisonbetween bipolar hemiarthroplasty and THA for osteonecrosis of the femoral head. Clin Orthop Relat Res2004; 424: 161—165.
38.
Kim YH, Oh SH, Kim JS, Koo KHContemporary total hip arthroplasty with and without cement in patients with osteonecrosis of the femoral-head. J Bone Joint Surg Am2003; 85: 675—681.
